+Vote!
Medical News Today (Free subscription) | 04/09/2008
Stem Cell Sciences plc (AIM:STEM, ASX:STC), a company focused on the commercialisation of stem cells and stem cell technologies, is pleased to announce that two independent laboratories in the UK and USA have achieved germ-line transmission from embryonic stem (ES) cells in rats using technologies exclusively licensed to the company by Edinburgh University.
+Vote!
Edinburgh Evening News (Free subscription) | 29/08/2008
STEM Cell Sciences, the company that recently moved its head offices from Edinburgh to Cambridge, said the relocation is likely to save it £1 million over two years.
+Vote!
Red Orbit (Free subscription) | 20/06/2008
Stem Cell Sciences has licensed certain rights to green fluorescent protein technology from Prolume.
+Vote!
Edinburgh Evening News (Free subscription) | 05/06/2008
STEM Cell Sciences, which recently announced that it planned to move its headquarters from Edinburgh to Cambridge, has secured a key European patent.
+Vote!
Scotsman.com (Free subscription) | 27/02/2008
STEM Cell Sciences, the biotech group which earlier this month announced it was leaving Edinburgh, has reported widening losses and falling sales but promised 2008 will be “tr
+Vote!
Edinburgh Evening News (Free subscription) | 27/02/2008
STEM Cell Sciences, which recently announced that it planned to move its headquarters from Edinburgh to Cambridge, has reported widening losses over its latest business year
+Vote!
The Herald (Free subscription) | 16/02/2008
Stem Cell Sciences, the pioneering Edinburgh University spin-out whose technology has put Scotland on the global front line of medical and pharmaceutical research, is to quit the country after its rent was hiked by almost 50%.
+Vote!
Fiercebiotech (Free subscription) | 31/01/2008
Stem Cell Sciences says a new pact with the Myelin Repair Foundation will provide it with a stable supply of uniform human brain cells for their research program on multiple sclerosis. Read more...
+Vote!
The Herald (Free subscription) | 31/01/2008
Stem Cell Sciences, the pioneering Edinburgh University spin-out, yesterday said it had signed a deal with US-based Myelin Repair Foundation that will boost efforts to discover new treatments for multiple sclerosis.
+Vote!
Patent Docs (Free subscription) | 31/01/2008
By Jason Derry -- Stem Cell Sciences plc has announced an agreement with Myelin Repair Foundation (MRF) to develop methods for generating sustainable cultures of human brain cells. Under the terms of the agreement, MRF will work on developing methods for culturing neural stem cells, and inducing the stem cells...
+Vote!
The Herald (Free subscription) | 26/12/2007
Stem Cell Sciences (SCS), the pioneering Edinburgh University spin-out, has signed a research agreement with a “major pharmaceutical company” to help develop drugs to treat diabetes.
+Vote!
Scotsman.com (Free subscription) | 20/11/2007
STEM Cell Sciences, the Edinburgh-based biotechnology firm, has appointed a new chief executive to replace the company's founder, Dr Peter Mountford.
+Vote!
The Herald (Free subscription) | 24/10/2007
Stem Cell Sciences, the pioneering Edinburgh University spin-out that aims to cure degenerative disorders, yesterday it had signed an agreement with San Raffaele Scientific Institute in Milan covering the testing and commercialisation of human muscle stem cells.
+Vote!
Scotsman.com (Free subscription) | 24/10/2007
THE biotechnology company Stem Cell Sciences (SCS) has landed a licensing deal with an Italian institute for a new stem cell line.
+Vote!
Medical News Today (Free subscription) | 28/09/2007
Stem Cell Sciences plc (SCS; AIM:STEM, ASX: STC) announces that it is to lead an EU funded, multinational novel drug screening collaboration using stem cells. [click link for full article]
